Federal Register: May 9, 2005 (Volume 70, Number 88)
DOCID: FR Doc 05-9177
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
NOTICE: NOTICES
ACTION: Applications, hearings, determinations, etc.:
SUBJECT CATEGORY:
Manufacturer of Controlled Substances; Notice of Registration
DOCUMENT SUMMARY:
By Notice dated June 28, 2004, and published in the Federal
Register on July 13, 2004, (69 FR 42068), EliElsohly Laboratories,
Inc., Mahmoud A. Elsohly PhD., 5 Industrial Park Drive, Oxford,
Mississippi 38655, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in Schedule I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Morphine (9300)............................ II
The company plans to manufacture the listed controlled substances for use in analysis and drug test standards.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of EliElsohly Laboratories, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated EliElsohly Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33(a), the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: May 2, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 059177 Filed 5605; 8:45 am]
BILLING CODE 441009P
SUMMARY:
Eli-Elsohly Laboratories, Inc.,
DOCUMENT BODY 2:
By Notice dated June 28, 2004, and published in the Federal
Register on July 13, 2004, (69 FR 42068), EliElsohly Laboratories,
Inc., Mahmoud A. Elsohly PhD., 5 Industrial Park Drive, Oxford,
Mississippi 38655, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in Schedule I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Morphine (9300)............................ II
The company plans to manufacture the listed controlled substances for use in analysis and drug test standards.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of EliElsohly Laboratories, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated EliElsohly Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33(a), the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: May 2, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 059177 Filed 5605; 8:45 am]
BILLING CODE 441009P